Abstract

Bioluminescence imaging (BLI) is ubiquitous in scientific research for the sensitive tracking of biological processes in small animal models. However, due to the attenuation of visible light by tissue, and the limited set of near-infrared bioluminescent enzymes, BLI is largely restricted to monitoring single processes in vivo. Here we show, that by combining stabilised colour mutants of firefly luciferase (FLuc) with the luciferin (LH2) analogue infraluciferin (iLH2), near-infrared dual BLI can be achievedin vivo. The X-ray crystal structure of FLuc with a high-energy intermediate analogue, 5'-O-[N-(dehydroinfraluciferyl)sulfamoyl] adenosine (iDLSA) provides insight into the FLuc-iLH2 reaction leading to near-infrared light emission. The spectral characterisation and unmixing validation studies reported here established that iLH2 is superior to LH2 for the spectral unmixing of bioluminescent signals in vivo; which led to this novel near-infrared dual BLI system being applied to monitor both tumour burden and CAR T cell therapy within a systemically induced mouse tumour model.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Raw image files are available on Dryad Digital repository, at doi:10.5061/dryad.3j9kd51cs.

The following data sets were generated

Article and author information

Author details

  1. Cassandra L Stowe

    Cancer Institute, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Thomas A Burley

    Institute of Cancer Research, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Helen Allan

    Department of Chemistry, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Maria Vinci

    Institute of Cancer Research, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Gabriela Kramer-Marek

    Institute of Cancer Research, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Daniela M Ciobota

    Institute of Cancer Research, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Gary N Parkinson

    School of Pharmacy, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Tara L Southworth

    Department of Chemistry, Connecticut College, New London, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Giulia Agliardi

    Cancer Institute, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Alastair Hotblack

    Cancer Institute, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Mark F Lythgoe

    Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Bruce R Branchini

    Department of Chemistry, Connecticut College, New London, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Tammy L Kalber

    Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. James C Anderson

    Department of Chemistry, University College London, London, United Kingdom
    For correspondence
    j.c.anderson@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8120-4125
  15. Martin A Pule

    Cancer Institute, University College London, London, United Kingdom
    For correspondence
    m.pule@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Science Foundation (MCB-1410390)

  • Tara L Southworth
  • Bruce R Branchini

Air Force Office of Scientific Research (FA9550-18-1-0017)

  • Tara L Southworth
  • Bruce R Branchini

Engineering and Physical Sciences Research Council (EP/L504889/1)

  • Helen Allan
  • James C Anderson

University College London

  • Helen Allan
  • James C Anderson

Biotechnology and Biological Sciences Research Council

  • Cassandra L Stowe

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were conducted in accordance with the Home Office Scientific Procedures Act (1986), within the guidelines of the relevant personal and project licences.

Copyright

© 2019, Stowe et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,527
    views
  • 730
    downloads
  • 51
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Cassandra L Stowe
  2. Thomas A Burley
  3. Helen Allan
  4. Maria Vinci
  5. Gabriela Kramer-Marek
  6. Daniela M Ciobota
  7. Gary N Parkinson
  8. Tara L Southworth
  9. Giulia Agliardi
  10. Alastair Hotblack
  11. Mark F Lythgoe
  12. Bruce R Branchini
  13. Tammy L Kalber
  14. James C Anderson
  15. Martin A Pule
(2019)
Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin
eLife 8:e45801.
https://doi.org/10.7554/eLife.45801

Share this article

https://doi.org/10.7554/eLife.45801

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Ana Patrícia Graça, Vadim Nikitushkin ... Gerald Lackner
    Research Article

    Mycofactocin is a redox cofactor essential for the alcohol metabolism of mycobacteria. While the biosynthesis of mycofactocin is well established, the gene mftG, which encodes an oxidoreductase of the glucose-methanol-choline superfamily, remained functionally uncharacterized. Here, we show that MftG enzymes are almost exclusively found in genomes containing mycofactocin biosynthetic genes and are present in 75% of organisms harboring these genes. Gene deletion experiments in Mycolicibacterium smegmatis demonstrated a growth defect of the ∆mftG mutant on ethanol as a carbon source, accompanied by an arrest of cell division reminiscent of mild starvation. Investigation of carbon and cofactor metabolism implied a defect in mycofactocin reoxidation. Cell-free enzyme assays and respirometry using isolated cell membranes indicated that MftG acts as a mycofactocin dehydrogenase shuttling electrons toward the respiratory chain. Transcriptomics studies also indicated remodeling of redox metabolism to compensate for a shortage of redox equivalents. In conclusion, this work closes an important knowledge gap concerning the mycofactocin system and adds a new pathway to the intricate web of redox reactions governing the metabolism of mycobacteria.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Santi Mestre-Fos, Lucas Ferguson ... Jamie HD Cate
    Research Article

    Stem cell differentiation involves a global increase in protein synthesis to meet the demands of specialized cell types. However, the molecular mechanisms underlying this translational burst and the involvement of initiation factors remains largely unknown. Here, we investigate the role of eukaryotic initiation factor 3 (eIF3) in early differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (NPCs). Using Quick-irCLIP and alternative polyadenylation (APA) Seq, we show eIF3 crosslinks predominantly with 3’ untranslated region (3’-UTR) termini of multiple mRNA isoforms, adjacent to the poly(A) tail. Furthermore, we find that eIF3 engagement at 3’-UTR ends is dependent on polyadenylation. High eIF3 crosslinking at 3’-UTR termini of mRNAs correlates with high translational activity, as determined by ribosome profiling, but not with translational efficiency. The results presented here show that eIF3 engages with 3’-UTR termini of highly translated mRNAs, likely reflecting a general rather than specific regulatory function of eIF3, and supporting a role of mRNA circularization in the mechanisms governing mRNA translation.